Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CV Sciences (CVSI) Notes Payables (2016 - 2022)

CV Sciences' Notes Payables history spans 9 years, with the latest figure at $952000.0 for Q2 2022.

  • For Q2 2022, Notes Payables fell 68.25% year-over-year to $952000.0; the TTM value through Jun 2022 reached $952000.0, down 68.25%, while the annual FY2021 figure was $612000.0, N/A changed from the prior year.
  • Notes Payables for Q2 2022 was $952000.0 at CV Sciences, down from $1.0 million in the prior quarter.
  • Across five years, Notes Payables topped out at $3.0 million in Q2 2021 and bottomed at $66883.0 in Q1 2018.
  • The 5-year median for Notes Payables is $739409.0 (2018), against an average of $1.0 million.
  • The largest annual shift saw Notes Payables skyrocketed 4663.52% in 2018 before it crashed 92.04% in 2019.
  • A 5-year view of Notes Payables shows it stood at $866818.0 in 2018, then plummeted by 92.04% to $69000.0 in 2019, then surged by 426.09% to $363000.0 in 2020, then surged by 68.6% to $612000.0 in 2021, then skyrocketed by 55.56% to $952000.0 in 2022.
  • Per Business Quant, the three most recent readings for CVSI's Notes Payables are $952000.0 (Q2 2022), $1.0 million (Q1 2022), and $612000.0 (Q4 2021).